Invitae Corporation
NVTANYSEHealthcare
$0.02
$-0.01(-35.59%)
Market Cap$5443367
P/E Ratio—
52W High$2.34
52W Low$0.015
Invitae Corporation (NVTA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NVTA · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2024Report Date: Feb 27, 2024EPS Actual
-$0.34
Est. -$0.30 · -13.3%
Revenue
—
Est. $0.12B
Fiscal Period
Q1 FY2024
FY ends December
Report Date
Feb 27, 2024
After Market Close
▼ Miss EPS
NVTA reports quarterly as a NYSE-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2024 | Nov 6, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 6, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 7, 2024 | — | — | — | — | — | — |
| ▼ Q1 FY2024 | Feb 27, 2024 | -$0.30 | -$0.34 | -13.3% | — | $0.12B | — |
| ▲ Q4 FY2023 | Nov 8, 2023 | -$0.30 | -$0.10 | +66.7% | $0.12B | $0.13B | -3.4% |
| ▲ Q3 FY2023 | Aug 8, 2023 | -$0.37 | -$0.30 | +18.9% | $0.12B | $0.12B | +0.3% |
| ▲ Q2 FY2023 | May 9, 2023 | -$0.41 | -$0.37 | +9.8% | $0.12B | $0.12B | +0.7% |
| ▲ Q1 FY2023 | Feb 28, 2023 | -$0.55 | -$0.34 | +38.2% | $0.12B | $0.12B | +1.0% |
Q4 FY2024
Nov 6, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 6, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 27, 2024Miss
EPS Actual
-$0.34
EPS Est.
-$0.30
EPS Surpr.
-13.3%
Revenue
—
Q4 FY2023
Nov 8, 2023Beat
EPS Actual
-$0.10
EPS Est.
-$0.30
EPS Surpr.
+66.7%
Revenue
$0.12B
Q3 FY2023
Aug 8, 2023Beat
EPS Actual
-$0.30
EPS Est.
-$0.37
EPS Surpr.
+18.9%
Revenue
$0.12B
Q2 FY2023
May 9, 2023Beat
EPS Actual
-$0.37
EPS Est.
-$0.41
EPS Surpr.
+9.8%
Revenue
$0.12B
Q1 FY2023
Feb 28, 2023Beat
EPS Actual
-$0.34
EPS Est.
-$0.55
EPS Surpr.
+38.2%
Revenue
$0.12B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.90 | $1.54 | $1.26 | 2 |
| Q2 FY2024 | $1.65 | $1.34 | $1.10 | 2 |
| Q1 FY2024 | $1.94 | $1.58 | $1.29 | 6 |
| Q4 FY2023 | $-0.33 | $-0.30 | $-0.25 | 8 |
| Q3 FY2023 | $-0.34 | $-0.31 | $-0.23 | 8 |
| Q2 FY2023 | $-0.45 | $-0.37 | $-0.30 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.2B | $0.3B | $0.3B | 3 |
| Q2 FY2024 | $0.2B | $0.2B | $0.3B | 3 |
| Q1 FY2024 | $0.1B | $0.1B | $0.2B | 6 |
| Q4 FY2023 | $0.1B | $0.1B | $0.1B | 7 |
| Q3 FY2023 | $0.1B | $0.1B | $0.1B | 7 |
| Q2 FY2023 | $0.1B | $0.1B | $0.1B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2024 | Feb 27, 2024 | -13.3% | $0.01 | $0.01 | +0.00% |
| ▲ Q4 FY2023 | Nov 8, 2023 | +66.7% | $0.68 | $0.69 | +0.75% |
| ▲ Q3 FY2023 | Aug 8, 2023 | +18.9% | $1.17 | $1.20 | +2.56% |
| ▲ Q2 FY2023 | May 9, 2023 | +9.8% | $1.63 | $1.61 | -1.23% |
| ▲ Q1 FY2023 | Feb 28, 2023 | +38.2% | $2.02 | $2.15 | +6.44% |
| ▲ Q4 FY2022 | Nov 8, 2022 | +28.8% | $2.40 | $2.35 | -2.08% |
| ▲ Q3 FY2022 | Aug 9, 2022 | +8.1% | $2.52 | $2.29 | -9.13% |
| ▼ Q2 FY2022 | May 3, 2022 | -1.3% | $5.60 | $5.57 | -0.54% |
Q1 FY2024+0.00%
Report Date
Feb 27, 2024
EPS Beat/Miss
-13.3%
Price Before
$0.01
Price After
$0.01
Q4 FY2023+0.75%
Report Date
Nov 8, 2023
EPS Beat/Miss
+66.7%
Price Before
$0.68
Price After
$0.69
Q3 FY2023+2.56%
Report Date
Aug 8, 2023
EPS Beat/Miss
+18.9%
Price Before
$1.17
Price After
$1.20
Q2 FY2023-1.23%
Report Date
May 9, 2023
EPS Beat/Miss
+9.8%
Price Before
$1.63
Price After
$1.61
Q1 FY2023+6.44%
Report Date
Feb 28, 2023
EPS Beat/Miss
+38.2%
Price Before
$2.02
Price After
$2.15
Q4 FY2022-2.08%
Report Date
Nov 8, 2022
EPS Beat/Miss
+28.8%
Price Before
$2.40
Price After
$2.35
Q3 FY2022-9.13%
Report Date
Aug 9, 2022
EPS Beat/Miss
+8.1%
Price Before
$2.52
Price After
$2.29
Q2 FY2022-0.54%
Report Date
May 3, 2022
EPS Beat/Miss
-1.3%
Price Before
$5.60
Price After
$5.57
Avg Beat Reaction-0.45%
Avg Miss Reaction-0.27%
Beat Rate6 / 8 quarters
Largest Move-9.13% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NVTA ends December
Invitae Corporation (NVTA) most recently reported earnings on February 27, 2024 for Q1 FY2024, posting EPS of $-0.34 — missing the analyst consensus of $-0.30 by -13.3%. The next NVTA earnings date is expected around September 1, 2026.
Each quarter, investors track NVTA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NVTA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NVTA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NVTA earnings · 5 questionsInvitae Corporation's next earnings report is expected around September 1, 2026. NVTA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NVTA historically reports after market close (AMC).
NVTA earnings datewhen is NVTA earningsNVTA next earnings datewhen does NVTA report earningsNVTA earnings calendar
▸ Source: FMP · Invitae Corporation SEC filings · US GAAP · Invitae Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026